The Federal Trade Commission (FTC) has expressed its disappointment at a Supreme Court decision relating to AndroGel (testosterone gel), a prescription medicine 2 August 2021
USA-based healthcare giant Johnson & Johnson, together with three major drug distributors, are ready to agree to a $26 billion settlement in connection with law 21 July 2021
An Expert View on the pros and cons of intellectual property (IP) protections in the pharmaceutical sector from White & Case partners' competition lawyer.James 20 July 2021
Following investigations from the UK’s Competition and Markets Authority (CMA), fines of around £260 million ($360 million) have been imposed on several pharmac 15 July 2021
Leading UK scientists have warned the government that patent protections on COVID-19 vaccines threaten the security of the country’s vaccination program and cou 12 July 2021
Troubled drugmaker Purdue Pharma has stepped a little closer to emerging from bankruptcy, after securing the backing of 15 states for a settlement related to cl 9 July 2021
US healthcare giant Johnson & Johnson is to pay $230 million to the state of New York in a settlement over accountability for the opioid epidemic ahead of a cou 28 June 2021
Cambridge, UK-based drugmaker AstraZeneca has welcomed a ruling by the Court of First Instance, in Brussels, which vindicated the company’s approach to the dist 18 June 2021
Advanced therapy trade group The Alliance for Regenerative Medicine (ARM) has highlighted the passage of a new piece of legislation designed to accelerate patie 15 June 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.